CMS Coverage, FDA Review Process Overlap Studied By HHS Secretary Panel

The HHS Secretary's Advisory Committee on Regulatory Reform will consider proposals to coordinate CMS' coverage analysis process with FDA's evaluation of new technologies to prevent duplicative requirements